Viewing data from:

CEFUROXIME AXETIL

ANDA

CEFUROXIME AXETIL | A065308 | AUROBINDO PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 12 NDCs

Highest NADAC/Unit

$0.3723

per ea

Lowest NADAC/Unit

$0.2977

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
65862070060CEFUROXIME AXETIL 500 MG TAB	$0.3723	EA	Generic	—	2026-06-17
16714040101CEFUROXIME AXETIL 500 MG TAB	$0.3723	EA	Generic	—	2026-06-17
16714040102CEFUROXIME AXETIL 500 MG TAB	$0.3723	EA	Generic	—	2026-06-17
57237005920CEFUROXIME AXETIL 500 MG TAB	$0.3723	EA	Generic	—	2026-06-17
57237005960CEFUROXIME AXETIL 500 MG TAB	$0.3723	EA	Generic	—	2026-06-17
65862070020CEFUROXIME AXETIL 500 MG TAB	$0.3723	EA	Generic	—	2026-06-17

Showing 6 of 12 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain18 active DMFs14 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

LUPIN LTDCEFUROXIME AXETIL (CRYSTALLINE) USP

DMF 147692000

LUPIN LTDCEFUROXIME AXETIL (AMORPHOUS) USP

DMF 161082002

WOCKHARDT LTDCEFUROXIME AXETIL (AMORPHOUS)

DMF 162672002

ORCHID PHARMA LTDCEFUROXIME AXETIL, AMORPHOUS

DMF 171342004

ORCHID PHARMA LTDCEFUROXIME AXETIL, CRYSTALLINE

DMF 171352004

APITORIA PHARMA PRIVATE LTDCEFUROXIME AXETIL USP

DMF 177072004

UNIMARK REMEDIES LTDCEFUROXIME AXETIL USP

DMF 205452007

PURE AND CURE HEALTHCARE PRIVATE LIMITEDCEFUROXIME AXETIL USP (CRYSTALLINE)

DMF 216152008

PURE AND CURE HEALTHCARE PRIVATE LTDCEFUROXIME AXETIL USP (AMORPHOUS)

DMF 216712008

NECTAR LIFESCIENCES LTDCEFUROXIME AXETIL USP (CRYSTALLINE)

DMF 223272008

NECTAR LIFESCIENCES LTDCEFUROXIME AXETIL USP (AMORPHOUS)

DMF 224262009

PURE AND CURE HEALTHCARE PRIVATE LTDCEFUROXIME AXETIL CRYSTALLINE ( PROCESS-II )

DMF 234532010

PURE AND CURE HEALTHCARE PRIVATE LTDCEFUROXIME AXETIL (AMORPHOUS) PROCESS II USP

DMF 236962010

ORCHID PHARMA LTDCEFUROXIME AXETIL (CRYSTALLINE) (NON-STERILE BULK API)

DMF 238912010

PURE AND CURE HEALTHCARE PRIVATE LTDCEFUROXIME AXETIL - AMORPHOUS (PROCESS-III) USP

DMF 245372011

PURE AND CURE HEALTHCARE PRIVATE LTDCEFUROXIME AXETIL (CRYSTALLINE) PROCESS-III

DMF 245842011

COVALENT LABORATORIES PRIVATE LTDCEFUROXIME AXETIL USP (AMORPHOUS)

DMF 250752011

SINOPHARM WEIQIDA PHARMACEUTICAL CO LTDCEFUROXIME AXETIL

DMF 361982021

FARMABIOS SRLInactiveCEFUROXIME

DMF 140101999

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCEFUROXIME AXETIL USP (CRYSTALLINE)

DMF 140581999

RANBAXY LABORATORIES LTDInactiveCEFUROXIME AXETIL

DMF 140741999

FAKO ILACLARI ASInactiveCEFUROXIME AXETIL AMORPHOUS

DMF 146532000

GLAXO WELLCOME INCInactiveCEFUROXIME AXETIL BULK DRUG SUBSTANCE

DMF 149922000

ACS DOBFAR SPAInactiveCEFUROXIME FOR INJECTION (75G AND 225G BULK PACKS)

DMF 152342001

WOCKHARDT LTDInactiveCEFUROXIME AXETIL (AMORPHOUS)

DMF 154512001

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCEFUROXIME AXETIL USP

DMF 157952001

SANDOZ PRIVATE LTDInactiveCEFUROXIME AXETIL

DMF 158152002

PHLOX PHARMACEUTICALS LTDInactiveCEFUROXIME AXETIL, USP (AMORPHOUS)

DMF 159802002

OLON SPAInactiveCEFUROXIME AXETIL

DMF 163502003

NECTAR LIFESCIENCES LTDInactiveCEFUROXIME AXETIL AMORPHOUS USP

DMF 195702006

TITAN PHARMACEUTICAL CO LTD GUANGDONGInactiveCEFUROXIME AXETIL DRUG SUBSTANCE

DMF 207502007

COVALENT LABORATORIES PRIVATE LTDInactiveCEFUROXIME AXETIL USP (CRYSTALLINE)

DMF 232372009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — EQ 125MG BASE

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 29, 2006

No patent or exclusivity listings for this strength.

#002 — EQ 250MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 29, 2006

#003 — EQ 500MG BASE

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 29, 2006